Clinical Trials Browser

Phase 1/2 × Active not recruiting × Temozolomide × Clear all

NCT03830918 2026-02-12

Niraparib, Temozolomide and Atezolizumab in Treating Patients With Advanced Solid Tumors and Extensive-Stage Small Cell Lung Cancer With a Complete or Partial Response to Platinum-Based First-Line Chemotherapy

Phase 1/2 Active not recruiting

Lung Neoplasms, Small Cell Lung Carcinoma

NCT04478279 2026-02-09

A Phase 1-2 Study of ST101 in Patients With Advanced Solid Tumors

Phase 1/2 Active not recruiting

BreastCNSDermatologicGenitourinary

Brain Neoplasms, Breast Neoplasms, Glioblastoma, Melanoma, Prostatic Neoplasms

NCT03491683 2026-01-28

INO-5401 and INO-9012 Delivered by Electroporation (EP) in Combination With Cemiplimab (REGN2810) in Newly-Diagnosed Glioblastoma (GBM)

Phase 1/2 Active not recruiting

Glioblastoma

NCT03212742 2025-12-04

OLA-TMZ-RTE-01

Phase 1/2 Active not recruiting

Glioma

NCT03687957 2025-11-25

rhIL-7-hyFc on Increasing Lymphocyte Counts in Patients With Newly Diagnosed Non-severe Lymphopenic Gliomas Following Radiation and Temozolomide

Phase 1/2 Active not recruiting

42 enrolled 19 charts

Glioma

NCT04910022 2025-08-19

Ph I/II Study of NMS-03305293+TMZ in Adult Patients With Recurrent Glioblastoma

Phase 1/2 Active not recruiting

Glioblastoma

NCT04881032 2025-02-13

NANO-GBM

Phase 1/2 Active not recruiting

Glioblastoma

NCT01985087 2024-10-31

A Study Using Radiation Therapy and Temozolomide to Treat Glioblastoma in Patients Over 70

Phase 1/2 Active not recruiting

Glioblastoma